These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2347040)

  • 1. The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pump.
    Radford JA; Margison JM; Swindell R; Lind MJ; Wilkinson PM; Thatcher N
    Cancer Chemother Pharmacol; 1990; 26(2):144-6. PubMed ID: 2347040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pump.
    Radford JA; Margison JM; Swindell R; Lind MJ; Wilkinson PM; Thatcher N
    J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S154-6. PubMed ID: 1795005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of ifosfamide in solutions for multiday infusion by external pump.
    Leone L; Comandone A; Oliva C; Bussi P; Goffredo F; Bretti S; Bumma C
    Anticancer Drugs; 1995 Aug; 6(4):604-7. PubMed ID: 7579566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion.
    Zhang Y; Kawedia JD; Myers AL; McIntyre CM; Anderson PM; Kramer MA; Culotta KS
    J Oncol Pharm Pract; 2014 Feb; 20(1):51-7. PubMed ID: 23512269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump.
    Hrubisko M; Mc Gown AT; Prendiville JA; Radford JA; Thatcher N; Fox BW
    Cancer Chemother Pharmacol; 1992; 29(3):252-5. PubMed ID: 1733559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I study of prolonged ambulatory infusion of Ifosfamide with oral mesna.
    Olver I; Keefe D; Myers M; Caruso D
    Chemotherapy; 2005 May; 51(2-3):142-6. PubMed ID: 15886474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas.
    Skubitz KM; Hamdan H; Thompson RC
    Cancer; 1993 Nov; 72(10):2963-9. PubMed ID: 8221562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suitability of carboplatin solutions for 14-day continuous infusion by ambulatory pump: an HPLC-dynamic FAB study.
    Hadfield JA; McGown AT; Dawson MJ; Thatcher N; Fox BW
    J Pharm Biomed Anal; 1993 Aug; 11(8):723-7. PubMed ID: 8257737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patients.
    Coriat R; Mir O; Camps S; Ropert S; Billemont B; Leconte M; Larousserie F; Anract P; Alexandre J; Goldwasser F
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):491-5. PubMed ID: 19588140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged 14-day continuous infusion of high-dose ifosfamide with an external portable pump: feasibility and efficacy in refractory pediatric sarcoma.
    Meazza C; Casanova M; Luksch R; Podda M; Favini F; Cefalo G; Massimino M; Ferrari A
    Pediatr Blood Cancer; 2010 Oct; 55(4):617-20. PubMed ID: 20589638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility.
    Cerny T; Graf A; Rohner P; Zeugin T; Brunner KW; Küpfer A
    J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S129-34. PubMed ID: 1795001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory treatment with 5 days continuous venous infusion of ifosfamide for advanced colorectal cancer: a phase II feasibility study.
    Focan C; Kreutz F; Levi F
    Anticancer Drugs; 1993 Aug; 4(4):459-62. PubMed ID: 8400348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of ifosfamide in 0.9% sodium chloride solution or water for injection in a portable i.v. pump cassette.
    Muñoz M; Girona V; Pujol M; Durán S; Vicente P; Solé LA
    Am J Hosp Pharm; 1992 May; 49(5):1137-9. PubMed ID: 1595743
    [No Abstract]   [Full Text] [Related]  

  • 14. Stability of benzylpenicillin potassium and ampicillin in an elastomeric infusion pump.
    Nakamura T; Enoki Y; Uno S; Uwamino Y; Iketani O; Hasegawa N; Matsumoto K
    J Infect Chemother; 2018 Oct; 24(10):856-859. PubMed ID: 29705391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the stability profile of anticancer drugs: A review of Ifosfamide and Mesna regimen for the treatment of metastatic soft tissue sarcoma.
    Salman D; Swinden J; Barton S; Peron JM; Nabhani-Gebara S
    J Oncol Pharm Pract; 2016 Feb; 22(1):86-91. PubMed ID: 25178698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basis.
    Bellmunt J; Eres N; Ribas A; Casado S; Albanell J; Baselga J
    Cancer Chemother Pharmacol; 1997; 40(3):273-6. PubMed ID: 9219513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide continuous infusion without mesna. A phase I trial of a 14-day cycle.
    Lokich I; Anderson N; Bern M; Moore C
    Cancer; 1991 Feb; 67(4):883-5. PubMed ID: 1899352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
    Menard C; Bourguignon C; Schlatter J; Vermerie N
    Ann Pharmacother; 2003 Dec; 37(12):1789-92. PubMed ID: 14632591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full-dose ifosfamide can be safely administered to outpatients.
    Meazza C; Bisogno G; Casanova M; Zanetti I; Carli M; Ferrari A
    Pediatr Blood Cancer; 2008 Feb; 50(2):375-8. PubMed ID: 16847930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of fentanyl citrate in 0.9% sodium chloride solution in portable infusion pumps.
    Allen LV; Stiles ML; Tu YH
    Am J Hosp Pharm; 1990 Jul; 47(7):1572-4. PubMed ID: 2368750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.